Integration of Antimicrobials and Delivery Systems: Synergistic Antibiofilm Activity with Biodegradable Nanoemulsions Incorporating Pseudopyronine Analogs
-
Published:2023-07-28
Issue:8
Volume:12
Page:1240
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Park Jungmi1ORCID,
Mahida Neel1,
Ho Gabrielle1,
Pena Elizabeth1,
Makabenta Jessa Marie V.1ORCID,
Aneke Stanley1,
Jiang Mingdi1ORCID,
Bouthillette Leah M.2,
Holz Stephanie E.2,
Hassan Muhammad Aamir1ORCID,
Wolfe Amanda L.2ORCID,
Rotello Vincent M.1ORCID
Affiliation:
1. Department of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA
2. Department of Chemistry and Biochemistry, University of North Carolina Asheville, Asheville, NC 28804, USA
Abstract
Multi-drug-resistant (MDR) bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), pose a significant challenge in healthcare settings. Small molecule antimicrobials (SMAs) such as α-pyrones have shown promise as alternative treatments for MDR infections. However, the hydrophobic nature of many SMAs limits their solubility and efficacy in complex biological environments. In this study, we encapsulated pseudopyronine analogs (PAs) in biodegradable polymer nanoemulsions (BNEs) for efficient eradication of biofilms. We evaluated a series of PAs with varied alkyl chain lengths and examined their antimicrobial activity against Gram-positive pathogens (S. aureus, MRSA, and B. subtilis). The selected PA with the most potent antibiofilm activity was incorporated into BNEs for enhanced solubility and penetration into the EPS matrix (PA-BNEs). The antimicrobial efficacy of PA-BNEs was assessed against biofilms of Gram-positive strains. The BNEs facilitated the solubilization and effective delivery of the PA deep into the biofilm matrix, addressing the limitations of hydrophobic SMAs. Our findings demonstrated that the PA2 exhibited synergistic antibiofilm activity when it was loaded into nanoemulsions. This study presents a promising platform for addressing MDR infections by combining pseudopyronine analogs with antimicrobial biodegradable nanoemulsions, overcoming challenges associated with treating biofilm infections.
Funder
Research Corporation for Science Advancement, North Carolina Biotechnology Center
esearch Corporation for Science Advancement Cottrell Scholar Award
National Institutes of Health
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference38 articles.
1. CDC (2019). Antibiotic Resistance Threats in The United States 2019.
2. Richardson, L.A. (2017). Understanding and Overcoming Antibiotic Resistance. PLoS Biol., 15.
3. The Antibiotic Resistance Crisis: Part 1: Causes and Threats;Ventola;Pharm. Ther.,2015
4. Bacterial Biofilm and Associated Infections;Jamal;J. Chin. Med. Assoc.,2018
5. Multidrug Resistance in Bacteria;Nikaido;Annu. Rev. Biochem.,2009
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献